Brief: GSK To Stop Manufacturing At Dresden, Germany Flu Vaccine Manufacturing Site In Summer 2027
11/09/2026 17:58
BRIEF-GSK To Stop Manufacturing At Dresden, Germany Flu Vaccine Manufacturing Site In Summer 2027 Sept 11 (Reuters) - GSK plc GSK.L:
GSK SAYS PLANS TO STOP MANUFACTURING AT CO'S DRESDEN, GERMANY FLU VACCINE MANUFACTURING SITE IN SUMMER 2027
Further company coverage: GSK.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on GSK
See all newsCorrected: UPDATE 1-UNICEF and Gavi agree to cut Mosqivac malaria vaccine price by 40% (Oct. 22)
Corrected: UNICEF and Gavi agree to cut Mosqivac malaria vaccine price by 40% (Oct. 22)
Citi says CSL's CEO pick brings key strengths
GSK is two shots away from clean bill of health
Brief: GSK Says US FDA Approves Hibsago For Chronic Hepatitis B